<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Nanoscale thymoquinone [
 <xref rid="B161-nanomaterials-09-00296" ref-type="bibr" class="xref">161</xref>], which was found to improve the anticancer roles of doxorubicin by upregulation of P53 and downregulation of Bcl2 and potentiate paclitaxelâ€™s apoptosis in MCF-7 breast cancer cells, could protect also against diabetes, inflammation, central nervous system, and hepatotoxicity primarily by enhancing the antioxidant status of organs and could be considered as a promising nutraceutical for human health [
 <xref rid="B162-nanomaterials-09-00296" ref-type="bibr" class="xref">162</xref>].
</p>
